Advanced basal cell carcinoma: What dermatologists need to know about treatment.

Wilson, Melissa; Johnson, Ryan P; Senft, Stephen C; Pan, Eva Y; Krakowski, Andrew C

Wilson, Melissa; Johnson, Ryan P; Senft, Stephen C; Pan, Eva Y; Krakowski, Andrew C.

Afiliação

Wilson M; St. Luke's Cancer Center, Easton. Electronic address: melissa.wilson@sluhn.org.
Johnson RP; St. Luke's University Health Network, Easton.
Senft SC; St. Luke's University Health Network, Easton.
Pan EY; Yale-New Haven Hospital, New Haven.
Krakowski AC; St. Luke's University Health Network, Easton.

J Am Acad Dermatol ; 86(6S): S14-S24, 2022 06.

Article em En | MEDLINE | ID: mdl-35577406

Assuntos

Antineoplásicos; Carcinoma Basocelular; Neoplasias Cutâneas; Anilidas/uso terapêutico; Antineoplásicos/uso terapêutico; Carcinoma Basocelular/tratamento farmacológico; Carcinoma Basocelular/metabolismo; Dermatologistas; Proteínas Hedgehog/metabolismo; Humanos; Neoplasias Cutâneas/tratamento farmacológico; Neoplasias Cutâneas/patologia

Palavras-chave

advanced basal cell carcinoma; cemiplimab; sonidegib; treatment; vismodegib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Basocelular / Antineoplásicos Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google